(Q24246618)

https://api.crossref.org/works/10.1002%2F14651858.CD003217.PUB2

A syndrome of asymmetric limb weakness with motor conduction block

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003217.PUB2

Multifocal motor neuropathy with conduction block: is it a distinct clinical entity?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003217.PUB2

High-dose intravenous immunoglobulin therapy in multifocal motor neuropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003217.PUB2

The sensitivity and specificity of anti-GM1 antibody testing

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003217.PUB2

How long is IVIg effective in multifocal motor neuropathy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003217.PUB2

Interobserver agreement for the assessment of handicap in stroke patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003217.PUB2

Immunosuppressive treatment of motor neuron syndromes. Attempts to distinguish a treatable disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003217.PUB2

7 January 2021

Multifocal motor neuropathy: diagnostic criteria that predict the response to immunoglobulin treatment

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003217.PUB2

7 January 2021

A treatable multifocal motor neuropathy with antibodies to GM1 ganglioside

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003217.PUB2

7 January 2021

Lower motor neuron syndromes defined by patterns of weakness, nerve conduction abnormalities, and high titers of antiglycolipid antibodies

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003217.PUB2

7 January 2021

A computer simulation of conduction block: effects produced by actual block versus interphase cancellation

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003217.PUB2

7 January 2021

Immunosuppressive treatment in multifocal motor neuropathy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003217.PUB2

7 January 2021

Pathological findings at the site of conduction block in multifocal motor neuropathy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003217.PUB2

7 January 2021

Multifocal motor neuropathy: response to human immune globulin

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003217.PUB2

7 January 2021

Sensory nerve pathology in multifocal motor neuropathy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003217.PUB2

7 January 2021

Consensus criteria for the diagnosis of multifocal motor neuropathy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003217.PUB2

7 January 2021

Mycophenolate mofetil in dysimmune neuropathies: a preliminary study.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003217.PUB2

7 January 2021

Multifocal acquired demyelinating neuropathy masquerading as motor neuron disease

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003217.PUB2

7 January 2021

Motor neuropathy with multifocal conduction blocks

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003217.PUB2

7 January 2021

Conduction block in clinical practice

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003217.PUB2

7 January 2021

Interobserver agreement in the assessment of muscle strength and functional abilities in Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003217.PUB2

7 January 2021

The clinical and diagnostic role of anti-GM1 antibody testing

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003217.PUB2

7 January 2021

Multifocal motor neuropathy presenting as ophthalmoplegia

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003217.PUB2

7 January 2021

Multifocal motor neuropathy without overt conduction block

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003217.PUB2

7 January 2021

Multifocal motor neuropathy with conduction block misdiagnosed as multiple entrapment neuropathies

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003217.PUB2

7 January 2021

Multifocal acquired demyelinating sensory and motor neuropathy: the Lewis-Sumner syndrome

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003217.PUB2

7 January 2021

Upper limb predominant, multifocal chronic inflammatory demyelinating polyneuropathy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003217.PUB2

7 January 2021

Multifocal motor neuropathy and Lewis Sumner syndrome: two distinct entities

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003217.PUB2

7 January 2021

Multifocal motor neuropathy and Lewis Sumner syndrome: a clinical spectrum

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003217.PUB2

7 January 2021

AAEM news and comments

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003217.PUB2

7 January 2021

Natural history of 46 patients with multifocal motor neuropathy with conduction block

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003217.PUB2

7 January 2021

Multifocal motor neuropathy: clinical and electrophysiological findings

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003217.PUB2

7 January 2021

Efficacy of cyclosporine treatment in multifocal motor neuropathy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003217.PUB2

7 January 2021

Intravenous immunoglobulin treatment in multifocal motor neuropathy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003217.PUB2

7 January 2021

Multifocal motor neuropathy mimicking motor neuron disease: nine cases

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003217.PUB2

7 January 2021

Multifocal motor neuropathy.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003217.PUB2

7 January 2021

79(th) ENMC International Workshop: multifocal motor neuropathy. 14-15 April 2000, Hilversum, The Netherlands

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003217.PUB2

7 January 2021

Inter-laboratory validation of an ELISA for the determination of serum anti-ganglioside antibodies

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003217.PUB2

7 January 2021

Mycophenolate in treatment-resistant inflammatory neuropathies

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003217.PUB2

7 January 2021

The long-term effect of intravenous immunoglobulin treatment in multifocal motor neuropathy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003217.PUB2

7 January 2021

Intravenous immunoglobulin therapy in multifocal motor neuropathy: a double-blind, placebo-controlled study.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003217.PUB2

7 January 2021

Multifocal motor neuropathy: long-term clinical and electrophysiological assessment of intravenous immunoglobulin maintenance treatment

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003217.PUB2

7 January 2021

Follow-up study and response to treatment in 23 patients with Lewis-Sumner syndrome

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003217.PUB2

7 January 2021

Chronic acquired demyelinating motor neuropathy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003217.PUB2

7 January 2021

Electrophysiological improvement after intravenous immunoglobulin in motor neuropathy with multifocal conduction block

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003217.PUB2

7 January 2021

Pure motor demyelinating neuropathy: deterioration after steroid treatment and improvement with intravenous immunoglobulin

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003217.PUB2

7 January 2021

Clinical and neurophysiological assessment of immunoglobulin therapy in five patients with multifocal motor neuropathy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003217.PUB2

7 January 2021

Human immunoglobulin treatment of multifocal motor neuropathy and polyneuropathy associated with monoclonal gammopathy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003217.PUB2

7 January 2021

Multifocal motor neuropathy with conduction block: a study of 24 patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003217.PUB2

7 January 2021

Treatment of multifocal motor neuropathy with high dose intravenous immunoglobulins: a double blind, placebo controlled study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003217.PUB2

7 January 2021

Long term follow up of multifocal motor neuropathy with conduction block under treatment

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003217.PUB2

7 January 2021

Long term effect of intravenous immunoglobulins and oral cyclophosphamide in multifocal motor neuropathy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003217.PUB2

7 January 2021

Chronic motor neuropathies: response to interferon-beta1a after failure of conventional therapies

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003217.PUB2

7 January 2021

Plasmapheresis in multifocal motor neuropathy: a case report

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003217.PUB2

7 January 2021

Treatment of IgM antibody associated polyneuropathies using rituximab

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003217.PUB2

7 January 2021

Motor Neuropathy with Proximal Multifocal Persistent Conduction Block, Fasciculations and Myokymia

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003217.PUB2

7 January 2021

Chronic neuropathy with IgM anti-ganglioside antibodies: lack of long term response to rituximab

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003217.PUB2

7 January 2021

Multifocal motor neuropathy: decrease in conduction blocks and reinnervation with long-term IVIg

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003217.PUB2

7 January 2021

Multifocal demyelinating neuropathy with persistent conduction block

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003217.PUB2

7 January 2021

Slow resolution of multifocal weakness and fasciculation: a reversible motor neuron syndrome

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003217.PUB2

7 January 2021

Multifocal demyelinating motor neuropathy: cranial nerve involvement and immunoglobulin therapy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003217.PUB2

7 January 2021

Intravenous immunoglobulin treatment in patients with motor neuron syndromes associated with anti-GM1 antibodies: a double-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003217.PUB2

7 January 2021

Multifocal motor neuropathy with conduction block after Campylobacter jejuni enteritis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003217.PUB2

7 January 2021

Pulsed high-dose dexamethasone is not effective in patients with multifocal motor neuropathy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003217.PUB2

7 January 2021

Magnetic resonance imaging of the brachial plexus in patients with multifocal motor neuropathy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003217.PUB2

7 January 2021

Multifocal motor neuropathy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003217.PUB2

7 January 2021

Deterioration of multifocal motor neuropathy after plasma exchange

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003217.PUB2

7 January 2021

Multifocal inflammatory demyelinating neuropathy: a distinct clinical entity?

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003217.PUB2

7 January 2021

Treatment of multifocal motor neuropathy with interferon-beta1A

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003217.PUB2

7 January 2021

Multifocal inflammatory demyelinating neuropathy: A distinct clinical entity?

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003217.PUB2

7 January 2021